Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

Individuals with IBD do not seem to incur an intrinsic risk of developing lymphoma. However, there is evidence to suggest that either alone or in combination with anti-TNF, the use of thiopurines ...

Henlius and Organon’s pertuzumab biosimilar met phase 3 goals; Meitheal expanded its US biosimilars; Celltrion’s subcutaneous ...

Although anti-inflammatory medicines like steroids still form part of the treatment for IBD, current treatment uses ...

And last month, at Festival of Biologics year of 2024, Abcsi has presented titled Development of an AI-designed therapeutic anti-TL1A antibody for IBD. Additional data for the ABS-101 program was ...

Handley thinks that phages might have a role in triggering IBD, a condition that can cause diarrhoea ... “That all gives a ...

SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- (“AltruBio” or “the Company”), a clinical-stage biotech company developing novel immune checkpoint enhancers to address the unmet need in ...

IND cleared by FDA and dosing in the Phase 1 clinical trial initiated, with data expected in the first half of 2025Sanofi ...

ADMA stock rocketed Friday after the biotech company inked a deal with KPMG as its new independent registered public accounting firm.

The primary endpoint was clinical remission at week 12, with secondary endpoints of clinical response and endoscopic ...